InvestorsHub Logo
Followers 54
Posts 4488
Boards Moderated 0
Alias Born 04/18/2009

Re: None

Thursday, 10/06/2016 2:29:04 PM

Thursday, October 06, 2016 2:29:04 PM

Post# of 2543
HUGE DD FIND:

If this has already been discovered, I apologize for wasting your time. I think this is the first time it has been mentioned though. Our CEO, Donald Nicholson, will be taking a seat on Integumen's board of directors. Also, Dr. Asculai will be appointed to Integumen's scientific advisory board.

https://www.lawinsider.com/contracts/1K0OhNyGaq7aFcz5bSGyA9/enhance-skin-products/1395400/2016-10-05

4.3 Actions of the Purchaser following Completion

Subject to the Seller satisfying its obligations set out in Part 1 of Schedule 2 prior to, or at, Completion the following shall occur:



(i) the Purchaser and Integumen shall pay the Consideration to the Seller in the manner specified in Clause 5; and

(ii) Integumen shall take all steps necessary to ensure Donald Nicholson shall be appointed as a Director of Integumen and Dr. Samuel Asculai shall be appointed to the scientific advisory board of Integumen as soon as reasonably practicable and that such appointments will continue for so long as the Seller or Related Parties owns at least 5% of the outstanding common stock of Integumen.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.